Transcription of A2018ReferenceGuidetotheBanffClassification of Renal ...
{{id}} {{{paragraph}}}
Downloadedfrom BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4 XMi0hCywCX1 AWnYQp/IlQrHD3lO0fy3 QXco/NzXmRwEGbz2bgRcGow+0v+DcHdF89 ZuGUwKj2xQoUHQ==on 01/18/2019 Downloadedfrom BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4 XMi0hCywCX1 AWnYQp/IlQrHD3lO0fy3 QXco/NzXmRwEGbz2bgRcGow+0v+DcHdF89 ZuGUwKj2xQoUHQ==on 01/18/2019A 2018 Reference Guide to the Banff Classificationof Renal Allograft PathologyCandice Roufosse, MD, PhD,1,2 Naomi Simmonds, MD,3 Marian Clahsen-van Groningen, MD, PhD,4 Mark Haas, MD, PhD,5 Kammi J. Henriksen, MD,6 Catherine Horsfield, MD,3 Alexandre Loupy, MD,7 Michael Mengel, MD,8 Agnieszka Perkowska-Ptasi ska, MD,9 Marion Rabant, MD, PhD,10 Lorraine C.
Category 2: Antibody-mediated changes Use the Diagnostic Criteria Groups (right column) to reach 1 Diagnosis (left column) Diagnoses Diagnostic Criteria Groups C4d Staining Without Evidence of Rejection Banff Lesion Score C4d > 1 (IF on fresh frozen tissue) OR C4d > 0 (IHC on paraffin-embedded tissue) AND Banff Lesion Scores t0, v0
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}